Oceania Healthcare Limited (NZE:OCA)
New Zealand
· Delayed Price · Currency is NZD | Market Cap | 528.69M |
| Revenue (ttm) | 259.60M |
| Net Income (ttm) | 52.42M |
| Shares Out | 724.23M |
| EPS (ttm) | 0.07 |
| PE Ratio | 10.09 |
| Forward PE | 8.32 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 398,626 |
| Average Volume | 421,337 |
| Open | 0.720 |
| Previous Close | 0.730 |
| Day's Range | 0.720 - 0.735 |
| 52-Week Range | 0.590 - 0.930 |
| Beta | 0.59 |
| RSI | 50.39 |
| Earnings Date | May 22, 2026 |
About Oceania Healthcare
Oceania Healthcare Limited, together with its subsidiaries, owns and operates retirement villages and care centres in New Zealand. It operates through three segments: Care Operations, Village Operations, and Other. The company offers traditional care beds and care suites; independent living and rental properties; and rest home, hospital, and specialist dementia services. It also provides accommodation, and care and related services to aged care residents; and accommodation and related services to independent residents in the retirement villages... [Read more]
Financial Performance
In fiscal year 2025, Oceania Healthcare's revenue was 260.57 million, a decrease of -1.84% compared to the previous year's 265.46 million. Earnings were 30.42 million, a decrease of -3.36%.
Financial StatementsNews
Oceania Healthcare Earnings Call Transcript: H1 2026
Underlying EBITDA rose 23% to $42M, with strong care profitability and cost savings driving results. Gearing improved to 34.8%, and debt reduction is expected to accelerate in the second half, supported by divestments and robust sales momentum.
Oceania Healthcare Transcript: AGM 2025
The meeting reviewed strong asset growth, a modernized portfolio, and improved financial leverage, but no dividend was declared for FY 2025. Strategic plans focus on care quality, sustainability, and operational efficiency, with robust risk management and board oversight.
Oceania Healthcare Earnings Call Transcript: H2 2025
Positive momentum in FY 2025 with improved sales, cost control, and asset growth. Underlying EBITDA rose 4.1% year-over-year, gearing decreased, and a major cost-out program is underway. Focus remains on sales, debt reduction, and portfolio modernization.
Oceania Healthcare Ltd (ASX:OCA) Half Year 2025 Earnings Call Highlights: Strong Occupancy and ...
Oceania Healthcare Ltd (ASX:OCA) Half Year 2025 Earnings Call Highlights: Strong Occupancy and Cash Flow Amidst Challenges
Half Year 2025 Oceania Healthcare Ltd Earnings Call Transcript
Half Year 2025 Oceania Healthcare Ltd Earnings Call Transcript
Oceania Healthcare Earnings Call Transcript: H1 2025
Underlying EBITDA rose 2.6% year-over-year, with strong cash inflow and reduced gearing to 37.5%. Focus is on accelerating sales, reducing unsold stock, and achieving NZD 5–7 million in cost savings for FY2026, while dividend resumption depends on sales and gearing.
Oceania Healthcare Transcript: AGM 2024
The meeting highlighted strong financial growth, strategic portfolio transformation, and a focus on sustainability and risk management. Shareholders discussed share price, dividends, and resident amenities, with the board addressing concerns and outlining future plans for growth and improved services.